These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 1387023
21. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure. Seymour AA, Asaad MM, Lanoce VM, Langenbacher KM, Fennell SA, Rogers WL. J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922 [Abstract] [Full Text] [Related]
22. Evaluation of SQ 28,603, an inhibitor of neutral endopeptidase, in conscious monkeys. Seymour AA, Abboa-Offei B, Asaad MM, Rogers WL. Can J Physiol Pharmacol; 1991 Oct; 69(10):1609-17. PubMed ID: 1663819 [Abstract] [Full Text] [Related]
23. Modulation of ANP-dependent effects of endothelin by inhibitors of neutral endopeptidase and cGMP phosphodiesterase. Valentin JP, Qiu C, Wiedemann E, Gardner DG, Humphreys MH. J Pharmacol Exp Ther; 1995 May; 273(2):744-52. PubMed ID: 7752077 [Abstract] [Full Text] [Related]
24. CGS 35601 and its orally active prodrug CGS 37808 as triple inhibitors of endothelin-converting enzyme-1, neutral endopeptidase 24.11, and angiotensin-converting enzyme. Trapani AJ, Beil ME, Bruseo CW, Savage P, Firooznia F, Jeng AY. J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S211-5. PubMed ID: 15838282 [Abstract] [Full Text] [Related]
25. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure. Margulies KB, Perrella MA, McKinley LJ, Burnett JC. J Clin Invest; 1991 Nov; 88(5):1636-42. PubMed ID: 1658047 [Abstract] [Full Text] [Related]
26. Sodium loads enhance the natriuretic responses to atrial natriuretic peptide and neutral endopeptidase inhibitors in conscious cynomolgus monkeys. Seymour AA, Asaad MM, Abboa-Offei B, Smith PL, Rogers WL. Clin Exp Pharmacol Physiol; 1994 Nov; 21(11):845-56. PubMed ID: 7882575 [Abstract] [Full Text] [Related]
27. Inhibition of neutral endopeptidase amplifies the effects of endogenous atrial natriuretic peptide on blood pressure and fluid partition. Valentin JP, Qiu CB, Wiedemann E, Gardner D, Humphreys MH. Am J Hypertens; 1992 Feb; 5(2):88-91. PubMed ID: 1532317 [Abstract] [Full Text] [Related]
28. Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors. Seymour AA, Mathers PD, Abboa-Offei BE, Asaad MM, Weber H. J Cardiovasc Pharmacol; 1996 Sep; 28(3):397-401. PubMed ID: 8877586 [Abstract] [Full Text] [Related]
29. Potentiation of the depressor responses to atrial natriuretic peptides in conscious SHR by an inhibitor of neutral endopeptidase. Seymour AA, Swerdel JN, Fennell SA, Druckman SP, Neubeck R, Delaney NG. J Cardiovasc Pharmacol; 1989 Aug; 14(2):194-204. PubMed ID: 2476591 [Abstract] [Full Text] [Related]
30. Heart failure augments the cardiovascular and renal effects of neutral endopeptidase inhibition in rats. Trippodo NC, Gabel RA, Harvey CM, Asaad MM, Rogers WL. J Cardiovasc Pharmacol; 1991 Sep; 18(3):308-16. PubMed ID: 1720829 [Abstract] [Full Text] [Related]
31. CGS 34226, a thiol-based dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11. Jeng AY, Savage P, Beil ME, Bruseo CW, Hoyer D, Fink CA, Trapani AJ. Clin Sci (Lond); 2002 Aug; 103 Suppl 48():98S-101S. PubMed ID: 12193064 [Abstract] [Full Text] [Related]
32. Renal and depressor effects of SQ 29,072, a neutral endopeptidase inhibitor, in conscious hypertensive rats. Seymour AA, Norman JA, Asaad MM, Fennell SA, Swerdel JN, Little DK, Dorso CR. J Cardiovasc Pharmacol; 1990 Jul; 16(1):163-72. PubMed ID: 1696660 [Abstract] [Full Text] [Related]
33. Potentiation of renal effects of atrial natriuretic factor-(99-126) by SQ 29,072. Seymour AA, Fennell SA, Swerdel JN. Hypertension; 1989 Jul; 14(1):87-97. PubMed ID: 2544529 [Abstract] [Full Text] [Related]
34. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats. Tarpey SB, Bennett T, Randall MD, Gardiner SM. Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732 [Abstract] [Full Text] [Related]
35. Involvement of capsaicin-sensitive neurones in the haemodynamic effects of exogenous vasoactive peptides: studies in conscious, adult Long Evans rats treated neonatally with capsaicin. Bachelard H, Gardiner SM, Kemp PA, Bennett T. Br J Pharmacol; 1992 Jan; 105(1):202-10. PubMed ID: 1375856 [Abstract] [Full Text] [Related]
36. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension. Fournié-Zaluski MC, Gonzalez W, Turcaud S, Pham I, Roques BP, Michel JB. Proc Natl Acad Sci U S A; 1994 Apr 26; 91(9):4072-6. PubMed ID: 8171037 [Abstract] [Full Text] [Related]
37. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart. Bauer WR, Neubauer S, Obitz G, Ertl G. J Mol Cell Cardiol; 1994 Apr 26; 26(4):527-37. PubMed ID: 8072008 [Abstract] [Full Text] [Related]
38. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure. Trippodo NC, Fox M, Natarajan V, Panchal BC, Dorso CR, Asaad MM. J Pharmacol Exp Ther; 1993 Oct 26; 267(1):108-16. PubMed ID: 8229737 [Abstract] [Full Text] [Related]
39. Effects of indomethacin on the regional haemodynamic responses to low doses of endothelins and sarafotoxin. Gardiner SM, Compton AM, Bennett T. Br J Pharmacol; 1990 May 26; 100(1):158-62. PubMed ID: 2196965 [Abstract] [Full Text] [Related]
40. No major role for atrial natriuretic peptide in the vasodilator response to endothelin-1 in the spontaneously hypertensive rat. Fozard JR, Part ML. Eur J Pharmacol; 1990 May 03; 180(1):153-9. PubMed ID: 2142091 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]